Jinfukang regulates integrin/Src pathway and anoikis mediating circulating lung cancer cells migration
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 267, 113473
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81774166, 81703987, 81973517)
- Shanghai Shenkang Hospital Development Center (SHDC12016114)
- Excellent Academic Leaders of Health and Family Planning System in Shanghai (2017BR044)
- Shanghai Sailing Program (17YF1419700)
This publication has 28 references indexed in Scilit:
- Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60Clinical Cancer Research, 2015
- The biology of circulating tumor cellsOncogene, 2015
- Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer CellsCancer Research, 2015
- Biology, detection, and clinical implications of circulating tumor cellsEMBO Molecular Medicine, 2014
- “Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary DiseasePLOS ONE, 2014
- Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancerDrug Discovery Today, 2014
- Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibilityScience, 2014
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancerNature Medicine, 2014
- Why does cancer therapy lack effective anti-metastasis drugs?Cancer Letters, 2013
- Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patientsCancer Chemotherapy and Pharmacology, 2009